Antitumor Effect of Chalcone Derivatives against Human Prostate (LNCaP and PC-3), Cervix HPV-Positive (HeLa) and Lymphocyte (Jurkat) Cell Lines and Their Effect on Macrophage Functions

Chalcones are synthetic and naturally occurring compounds that have been widely investigated as anticancer agents. In this work, the effect of chalcones 1–18 against the metabolic viability of cervical (HeLa) and prostate (PC-3 and LNCaP) tumor cell lines was tested, to compare the activity against solid and liquid tumor cells. Their effect was also evaluated on the Jurkat cell line. Chalcone 16 showed the highest inhibitory effect on the metabolic viability of the tested tumor cells and was selected for further studies. Recent antitumor therapies include compounds with the ability to influence immune cells on the tumor microenvironment, with immunotherapy being one actual goal in cancer treatment. Therefore, the effect of chalcone 16 on the expression of mTOR, HIF-1α, IL-1β, TNF-α, IL-10, and TGF-β, after THP-1 macrophage stimulation (none, LPS or IL-4), was evaluated. Chalcone 16 significantly increased the expression of mTORC1, IL-1β, TNF-α, and IL-10 of IL-4 stimulated macrophages (that induces an M2 phenotype). HIF-1α and TGF-β were not significantly affected. Chalcone 16 also decreased nitric oxide production by the RAW 264.7 murine macrophage cell line, this effect probably being due to an inhibition of iNOS expression. These results suggest that chalcone 16 may influence macrophage polarization, inducing the pro-tumoral M2 macrophages (IL-4 stimulated) to adopt a profile closer to the antitumor M1 profile.

[1]  Hongyun Li,et al.  Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer , 2022, Journal of Nanobiotechnology.

[2]  R. Medeiros,et al.  Cervical Cancer Outcome and Tumor-Associated Macrophages: Research Evidence , 2022, Immuno.

[3]  T. Janeczko,et al.  The modulating effect of methoxy-derivatives of 2'-hydroxychalcones on the release of IL-8, MIF, VCAM-1 and ICAM-1 by colon cancer cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  K. Kashfi,et al.  Macrophage Reprogramming and Cancer Therapeutics: Role of iNOS-Derived NO , 2021, Cells.

[5]  E. Sousa,et al.  Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages , 2021, Molecules.

[6]  E. Cicinelli,et al.  Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications. , 2021, Critical reviews in oncology/hematology.

[7]  T. Ren,et al.  The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications , 2021, Cellular Oncology.

[8]  Guohui Wan,et al.  Tumor‐associated macrophages in immunotherapy , 2021, The FEBS journal.

[9]  Mao-Hua Cai,et al.  The roles of tumor-associated macrophages in tumor angiogenesis and metastasis. , 2020, Cellular immunology.

[10]  Xikun Zhou,et al.  Tumor-Associated Macrophages: Recent Insights and Therapies , 2020, Frontiers in Oncology.

[11]  Yi Liu,et al.  Research Progress on Tumor-Associated Macrophages and Inflammation in Cervical Cancer , 2020, BioMed research international.

[12]  Ana C. Henriques,et al.  Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity. , 2019, European journal of medicinal chemistry.

[13]  Huiyin Lan,et al.  Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications , 2019, Journal of Hematology & Oncology.

[14]  Yan-Mei Zhang,et al.  Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment , 2019, Cell Death & Disease.

[15]  E. Sousa,et al.  1,2-Dihydroxyxanthone: Effect on A375-C5 Melanoma Cell Growth Associated with Interference with THP-1 Human Macrophage Activity , 2019, Pharmaceuticals.

[16]  H. M. Manukumar,et al.  Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review , 2019, European Journal of Medicinal Chemistry.

[17]  Min Young Yoo,et al.  Tumor-Associated Macrophages Enhance Tumor Hypoxia and Aerobic Glycolysis. , 2019, Cancer research.

[18]  Hua-Li Qin,et al.  Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review , 2018, European Journal of Medicinal Chemistry.

[19]  I. Amelio,et al.  The hypoxic tumour microenvironment , 2018, Oncogenesis.

[20]  C. Xing,et al.  Chalcone: A Privileged Structure in Medicinal Chemistry. , 2017, Chemical reviews.

[21]  C. Tsatsanis,et al.  Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization , 2017, The Journal of Immunology.

[22]  Michael P Hughes,et al.  Accurate quantification of apoptosis progression and toxicity using a dielectrophoretic approach. , 2016, The Analyst.

[23]  M. Pinto,et al.  Prenylated Chalcone 2 Acts as an Antimitotic Agent and Enhances the Chemosensitivity of Tumor Cells to Paclitaxel , 2016, Molecules.

[24]  M. Pinto,et al.  Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction. , 2015, Life sciences.

[25]  P. Kronqvist,et al.  Human breast cancer cells educate macrophages toward the M2 activation status , 2015, Breast Cancer Research.

[26]  J. Trzcińska-Danielewicz,et al.  Synergy of BID with doxorubicin in the killing of cancer cells , 2015, Oncology reports.

[27]  J. Mes,et al.  THP-1 cell line: an in vitro cell model for immune modulation approach. , 2014, International immunopharmacology.

[28]  M. Pinto,et al.  Evaluation of 2',4'-dihydroxy-3,4,5-trimethoxychalcone as antimitotic agent that induces mitotic catastrophe in MCF-7 breast cancer cells. , 2014, Toxicology letters.

[29]  Dudley Lamming,et al.  The TSC-mTOR pathway regulates macrophage polarization , 2013, Nature Communications.

[30]  R. Heer,et al.  A review of tasquinimod in the treatment of advanced prostate cancer , 2013, Drug design, development and therapy.

[31]  I. Sarethy,et al.  Antiproliferative Effect of Solanum nigrum on Human Leukemic Cell Lines , 2012, Indian journal of pharmaceutical sciences.

[32]  M. Pinto,et al.  Synthesis of a Natural Chalcone and Its Prenyl Analogs – Evaluation of Tumor Cell Growth‐Inhibitory Activities, and Effects on Cell Cycle and Apoptosis , 2012, Chemistry & biodiversity.

[33]  J. Mes,et al.  β-Glucans are involved in immune-modulation of THP-1 macrophages. , 2012, Molecular nutrition & food research.

[34]  Xiaojuan He,et al.  Inhibitory Effect of Astragalus Polysaccharides on Lipopolysaccharide-Induced TNF-α and IL-1β Production in THP-1 Cells , 2012, Molecules.

[35]  S. Goerdt,et al.  Knockout of HIF-1α in tumor-associated macrophages enhances M2 polarization and attenuates their pro-angiogenic responses. , 2010, Carcinogenesis.

[36]  M. Pinto,et al.  Improvement of the inhibitory effect of xanthones on NO production by encapsulation in PLGA nanocapsules , 2005, Journal of drug targeting.

[37]  M. E. Sousa,et al.  Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. , 2002, Bioorganic & medicinal chemistry.

[38]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[39]  M. Pinto,et al.  Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines. , 2012, Bioorganic & medicinal chemistry.

[40]  P. Kronqvist,et al.  Human breast cancer cells educate macrophages toward the M 2 activation status , 2022 .